A Case of Gabapentin-induced Myoclonus in a Type 2 Diabetic Patient with End-stage Renal Disease / 임상당뇨병
Journal of Korean Diabetes
;
: 171-173, 2011.
Article
in Korean
| WPRIM
| ID: wpr-726880
ABSTRACT
Development of myoclonus can manifest as a side effect of antiepileptic drugs in subjects with preexisting epilepsy, post-traumatic brain injury, encephalopathy, or focal and multifocal brain lesions. A 69-year-old male showed new onset severe myoclonus and confusion two days after taking 1200 mg gabapentin. The patient had end-stage renal disease secondary to type 2 diabetes and was receiving hemodialysis twice a week. After increasing hemodialysis to three times a week and discontinuing gabapentin, myoclonus spontaneously resolved. Here we report the first case of myoclonus in a Korean subject with diabetic renal failure. We recommend caution in the administration of gabapentin for diabetic subjects with renal disease.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Brain
/
Brain Injuries
/
Renal Dialysis
/
Epilepsy, Post-Traumatic
/
Cyclohexanecarboxylic Acids
/
Diabetic Neuropathies
/
Renal Insufficiency
/
Gamma-Aminobutyric Acid
/
Amines
/
Kidney Failure, Chronic
Limits:
Aged
/
Humans
/
Male
Language:
Korean
Journal:
Journal of Korean Diabetes
Year:
2011
Type:
Article
Similar
MEDLINE
...
LILACS
LIS